Wellington Management Group’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Sell |
21,390
-10,773
| -33% | -$508K | ﹤0.01% | 1711 |
|
|
2025
Q1 | $1.26M | Sell |
32,163
-66,935
| -68% | -$2.62M | ﹤0.01% | 1652 |
|
|
2024
Q4 | $5.37M | Sell |
99,098
-92,960
| -48% | -$5.03M | ﹤0.01% | 1330 |
|
|
2024
Q3 | $9.68M | Sell |
192,058
-180,599
| -48% | -$9.11M | ﹤0.01% | 1183 |
|
|
2024
Q2 | $16.4M | Buy |
372,657
+96,218
| +35% | +$4.23M | ﹤0.01% | 1009 |
|
|
2024
Q1 | $13.9M | Buy |
276,439
+19,247
| +7% | +$967K | ﹤0.01% | 1036 |
|
|
2023
Q4 | $15.5M | Sell |
257,192
-166,195
| -39% | -$10M | ﹤0.01% | 1005 |
|
|
2023
Q3 | $24.1M | Buy |
423,387
+10,118
| +2% | +$577K | ﹤0.01% | 899 |
|
|
2023
Q2 | $21.1M | Buy |
+413,269
| New | +$21.1M | ﹤0.01% | 931 |
|
|
2021
Q4 | – | Sell |
-483,887
| Closed | -$4.78M | – | 2251 |
|
|
2021
Q3 | $4.78M | Sell |
483,887
-32,409
| -6% | -$320K | ﹤0.01% | 1519 |
|
|
2021
Q2 | $5.33M | Sell |
516,296
-10,429
| -2% | -$108K | ﹤0.01% | 1489 |
|
|
2021
Q1 | $5.38M | Sell |
526,725
-173,275
| -25% | -$1.77M | ﹤0.01% | 1409 |
|
|
2020
Q4 | $7.58M | Buy |
+700,000
| New | +$7.58M | ﹤0.01% | 1245 |
|